false 0002121703 0002121703 2026-05-29 2026-05-29 0002121703 CIK0002121703:UnitsEachConsistingOfOneOrdinaryShareAndOnehalfOfOneWarrantMember 2026-05-29 2026-05-29 0002121703 CIK0002121703:OrdinaryShares0.0001ParValueMember 2026-05-29 2026-05-29 0002121703 CIK0002121703:WarrantsEachExercisableForOneOrdinaryShareAtExercisePriceOf11.50PerShareMember 2026-05-29 2026-05-29 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): May 29, 2026

 

FortuneX Acquisition Corporation

(Exact name of registrant as specified in its charter)

 

Cayman Islands   001-43307   N/A
(State or other jurisdiction
of incorporation)
  (Commission
File Number)
  (IRS Employer
Identification No.)

 

1185 Avenue of the Americas, 3rd Fl.
New York, NY

  10036
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (212) 612-1400

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation to the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of exchange on which registered

Units, each consisting of one ordinary share, and one-half of one warrant

  FXACU   The Nasdaq Stock Market LLC
Ordinary Shares, $0.0001 par value   FXAC   The Nasdaq Stock Market LLC

Warrants, each exercisable for one ordinary share at an exercise price of $11.50 per share

  FXACW   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

Item 8.01. Other Events.

 

As previously reported, on May 26, 2026, FortuneX Acquisition Corporation, a Cayman Islands exempted company (the “Company”) consummated an initial public offering (the “IPO”) of 7,500,000 units (the “Units”). The Units were sold at an offering price of $10.00 per Unit, generating total gross proceeds of $75,000,000.

 

On May 27, 2026, the Company announced that the underwriters of its initial public offering exercised in full their over-allotment option to purchase 1,125,000 additional units at $10.00 per unit upon the closing of the over-allotment option, generating gross proceeds of $11,250,000. The over-allotment option closed on May 29, 2026. Simultaneously with the closing of the over-allotment option, the Company consummated the private placement of an aggregate of 15,000 units (the “Private Placement Units”) to FortuneX Investment Partners Limited, the Sponsor, at price of $10.00 per Private Placement Unit, generating gross proceeds of approximately $150,000.

 

An audited balance sheet as of May 26, 2026, reflecting receipt of the proceeds upon consummation of the IPO has been issued by the Company and previously filed as Exhibit 99.1 to a Current Report on Form 8-K on June 3, 2026.

 

An unaudited pro forma balance sheet of the Company as of May 29, 2026, reflecting the consummation of the exercise in full of the underwriters’ over-allotment option and the related transactions, is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

 

The information contained in this Current Report shall not be deemed “filed” for purposes of Section

 

Item 9.01. Financial Statements and Exhibits.

 

  (d) Exhibits

 

Exhibit No.   Description
99.1   Unaudited Pro Forma Balance Sheet as of May 29, 2026
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

1

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  FortuneX Acquisition Corporation
   
Date: June 8, 2026 By: /s/ Daniel M. McCabe
  Name: Daniel M. McCabe
  Title: Chief Executive Officer

 

2

 

Exhibit 99.1

 

Unaudited Pro Forma Balance Sheet as of May 29, 2026   F-2
Notes to Unaudited Pro Forma Financial Statement   F-3

 

F-1

 

 

FORTUNEX ACQUISITION CORPORATION

UNAUDITED PRO FORMA BALANCE SHEET

May 29, 2026

 

    May 26,
2026
    Pro Forma
Adjustments
          As
Adjusted
 
          (Unaudited)           (Unaudited)  
Assets                              
Current Assets                              
Cash   $ 1,102,515     $ (149,650 )   (b)     $ 952,865  
Advance – related party     53,900       131,100     (c)       185,000  
Prepaid expenses     15,000       13,170     (c)       13,170  
              (15,000 )   (k)          
Total Current Assets     1,171,415       (20,345 )           1,151,035  
                               
Cash and investments held in Trust Account     75,750,000       11,250,000     (a)       87,148,790  
              149,625     (b)          
              (37,125 )   (d)          
              36,290     (e)          
Deferred offering costs     -       37,125     (d)       -  
              562,500     (g)          
              (599,625 )   (j)          
Total Assets   $ 76,921,415     $ 11,378,410           $ 88,299,825  
                               
Liabilities, Ordinary Shares Subject to Redemption and Shareholders’ Deficit                              
Current Liabilities                              
Accounts payable and accrued expenses   $ 14,260     $ (5,320 )   (c)     $ 10,390  
              1,450     (f)          
Over-allotment option liability     102,787       (102,787 )   (h)       -  
Total Current Liabilities     117,047       (106,657 )           10,390  
                               
Deferred underwriting fee payable     3,750,000       562,500     (g)       4,312,500  
Total Liabilities     3,867,047       455,843             4,322,890  
                               
Commitments and Contingencies (Note 6)                              
                               
Ordinary shares subject to possible redemption, $0.0001 par value, 500,000,000 shares authorized, 7,500,000 shares and 8,625,000 shares at redemption value of $10.10 and $10.10 per share, as actual and adjusted, respectively     75,750,000       11,250,000     (a)       87,148,790  
              36,290     (e)          
              112,500     (i)          
Shareholders’ Deficit                              
Ordinary shares, $0.0001 par value, 500,000,000 shares authorized, 3,991,929 shares and 4,006,929 shares issued and outstanding, as actual and adjusted, respectively (excluding 7,500,000 shares and 8,625,000 shares subject to possible redemption, as actual and adjusted, respectively)     400       1     (c)       401  
Accumulated deficit     (2,696,032 )     (25 )   (b)       (3,172,256 )
              (25 )   (c)          
              112,489     (c)          
              37,125     (c)          
              (36,290 )   (e)          
              (599,625 )   (j)          
              36,290     (e)          
              102,787     (h)          
              (112,500 )   (i)          
              (1,450 )   (f)          
              (15,000 )   (k)          
Total Shareholders’ Deficit     (2,695,632 )     (476,223 )           (3,171,855 )
Total Liabilities, Ordinary Shares Subject to Redemption and Shareholders’ Deficit   $ 76,921,415     $ 11,378,410           $ 88,299,825  

 

The accompany notes are an integral part of the unaudited pro forma financial statement.

 

F-2

 

 

FORTUNEX ACQUISITION CORPORATION
NOTES TO UNAUDITED PRO FORMA FINANCIAL STATEMENT

 

Note 1 — Closing of Over-allotment Option and Additional Private Placement Units

 

The accompanying unaudited Pro Forma Balance Sheet presents the Balance Sheet of FortuneX Acquisition Corporation (the “Company”) as of May 26, 2026, adjusted for the closing of the underwriters’ over-allotment option and related transactions which occurred on May 29, 2026 as described below.

 

On May 26, 2026, the Company consummated its initial public offering (“IPO”) of 7,500,000 units (the “Units” and, with respect to the ordinary shares included in the Units being offered, the “Public Shares”) at an offering price of $10.00 per Unit generating gross proceeds of $75,000,000. Simultaneously with the closing of the IPO, the Company consummated a private placement (the “Private Placement”) in which FortuneX Investment Partners Limited (the “Sponsor”) purchased 297,500 units (the “Private Placement Units”) at a price of $10.00 per Private Placement Unit, generating total gross proceeds of $2,975,000.

 

The Company granted the underwriters a 45-day option to purchase up to an additional 1,125,000 Units (the “Option Units”) at $10.00 per unit to cover over-allotments, if any. On May 27, 2026, the underwriters notified the Company of their exercise of the over-allotment option in full to purchase 1,125,000 additional units (the “Option Units”) at $10.00 per unit. The closing of the issuance and sale of the Option Units occurred on May 29, 2026, generating total gross proceeds of $11,250,000. Simultaneously with the closing of the over-allotment option, the Company consummated the private placement of an aggregate of 15,000 Private Placement Units to the Sponsor, at a price of $10.00 per Private Placement Unit, generating gross proceeds of approximately $150,000.

 

A total of $87,112,500 ($10.10 per Unit) of the net proceeds from the sales of Units in the IPO, the Option Units and the Private Placements Unit on May 26, 2026 and May 29, 2026, were placed in a trust account with Continental Stock Transfer& Trust acting as trustee.

 

F-3

 

 

Pro forma adjustments to reflect the sales of the Option Units and additional Private Placement Units described above are as follows:

 

Pro Forma Entries   Debit     Credit  
(a) Cash and investments held in Trust Account   $ 11,250,000          
  Ordinary share subject to possible redemption           $ 11,250,000  
  To record the sale of 1,125,000 Option Units at $10.00 per Unit                
                   
(b) Cash and investments held in Trust Account   $ 149,625          
  Bank fee     25          
  Cash           $ 149,650  
  To record the transfer of cash account to Trust account for trust overfunding and payment of underwriting commission                
                   
(c) Advance – related party   $ 131,100          
  Bank fee     25          
  Accrued administrative expense     5,320          
  Prepaid administrative fee     13,170          
  Ordinary share – non redeemable           $ 1  
  Accumulative deficit             112,489  
  Accumulative deficit             37,125  
  To record trust overfunding of $.10/unit x1,125,000 units and underwriter cash commission ($11,250,000.00 x 0.33%), and amounts due from sponsor were offset by D&O insurance to be purchased by the sponsor and prepayment of administrative fees                
                   
(d) Deferred offering costs   $ 37,125          
  Cash and investments held in Trust Account           $ 37,125  
  To record payment of underwriting commission ($11,250,000.00 x 0.33%)                
                   
(e) Cash and investments held in Trust Account   $ 36,290          
  Interest earned in investments held in Trust Account           $ 36,290  
  Accumulative deficit   $ 36,290          
  Ordinary share subject to possible redemption           $ 36,290  
  To record interest earned in Trust Account and to reclass interest income to temporary equity                
                   
(f) Administrative expense   $ 1,450          
  Accrued administrative expenses           $ 1,450  
  To record three days (May 27 to May 29, 2026) of administrative expense                
                   
(g) Deferred offering costs   $ 562,500          
  Deferred underwriting commission payable           $ 562,500  
  To record deferred underwriting commission (5% of the sale of Option Units proceeds)                
                   
(h) Over-allotment liability   $ 102,787          
  Accumulative deficit           $ 102,787  
  To reverse over-allotment option liability                
                   
(i) Accumulative deficit   $ 112,500          
  Ordinary share subject to possible redemption           $ 112,500  
  To reclass trust overfunding to temporary equity                
                   
(j) Accumulative deficit   $ 599,625          
  Deferred offering costs           $ 599,625  
  To record the charge of deferred offering costs to permanent equity                
                   
(k) Professional fees - audit   $ 15,000          
  Prepaid expenses           $ 15,000  
  To record audit fees and reclassify from prepaid expense                

 

F-4